Tower Research Capital (TRC)’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,047
| Closed | -$853 | – | 6344 |
|
|
2023
Q3 | $853 | Sell |
1,047
-11,672
| -92% | -$9.6K | ﹤0.01% | 5458 |
|
|
2023
Q2 | $11.7K | Buy |
12,719
+11,809
| +1,298% | +$10.5K | ﹤0.01% | 3940 |
|
|
2023
Q1 | $1K | Sell |
910
-247
| -21% | -$487 | ﹤0.01% | 5700 |
|
|
2022
Q4 | $3K | Sell |
1,157
-4,935
| -81% | -$8.47K | ﹤0.01% | 5286 |
|
|
2022
Q3 | $8K | Buy |
6,092
+3,630
| +147% | +$5.26K | ﹤0.01% | 4840 |
|
|
2022
Q2 | $3K | Buy |
2,462
+1,664
| +209% | +$3.48K | ﹤0.01% | 5450 |
|
|
2022
Q1 | $2K | Sell |
798
-435
| -35% | -$1.05K | ﹤0.01% | 5654 |
|
|
2021
Q4 | $3K | Buy |
+1,233
| New | +$2.86K | ﹤0.01% | 5534 |
|
|
2021
Q3 | – | Sell |
-2,102
| Closed | -$6K | – | 6334 |
|
|
2021
Q2 | $6K | Buy |
2,102
+1,838
| +696% | +$5.29K | ﹤0.01% | 4657 |
|
|
2021
Q1 | $1K | Sell |
264
-636
| -71% | -$2.16K | ﹤0.01% | 5246 |
|
|
2020
Q4 | $2K | Buy |
+900
| New | +$2.42K | ﹤0.01% | 4938 |
|
|
2020
Q2 | – | Sell |
-1,226
| Closed | -$2K | – | 5069 |
|
|
2020
Q1 | $2K | Buy |
1,226
+161
| +15% | +$590 | ﹤0.01% | 2671 |
|
|
2019
Q4 | $4K | Buy |
+1,065
| New | +$3.62K | ﹤0.01% | 2839 |
|
|
2019
Q3 | – | Sell |
-2,202
| Closed | -$8K | – | 4642 |
|
|
2019
Q2 | $8K | Buy |
+2,202
| New | +$42K | ﹤0.01% | 2724 |
|
|
2019
Q1 | – | Sell |
-266
| Closed | -$5K | – | 4444 |
|
|
2018
Q4 | $5K | Sell |
266
-704
| -73% | -$16.2K | ﹤0.01% | 2958 |
|
|
2018
Q3 | $30K | Buy |
+970
| New | +$26K | ﹤0.01% | 2078 |
|
|
2016
Q4 | – | Sell |
-4
| Closed | – | – | 4542 |
|
|
2016
Q3 | $0 | Buy |
+4
| New | +$168 | ﹤0.01% | 4661 |
|
|
2016
Q2 | – | Sell |
-17
| Closed | – | – | 5132 |
|
|
2016
Q1 | $0 | Sell |
17
-69
| -80% | -$1.51K | ﹤0.01% | 5144 |
|
|
2015
Q4 | $2K | Buy |
86
+69
| +406% | +$2.28K | ﹤0.01% | 3847 |
|
|
2015
Q3 | $1K | Buy |
+17
| New | +$599 | ﹤0.01% | 3710 |
|
|
2014
Q4 | – | Sell |
-28
| Closed | -$2K | – | 4855 |
|
|
2014
Q3 | $2K | Sell |
28
-46
| -62% | -$5.46K | ﹤0.01% | 3900 |
|
|
2014
Q2 | $10K | Buy |
74
+65
| +722% | +$8.61K | ﹤0.01% | 2389 |
|
|
2014
Q1 | $1K | Sell |
9
-296
| -97% | -$44.9K | ﹤0.01% | 4236 |
|
|
2013
Q4 | $46K | Buy |
+305
| New | +$49.6K | 0.01% | 1463 |
|
Other funds holding ACER
Tower Research Capital (TRC)'s ACER Position: Q4 2023 in Review
Tower Research Capital (TRC) sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 1,047 shares — an estimated $853 sold.
Tower Research Capital (TRC) first reported a position in ACER in Q4 2013 and held it in 24 quarters. The position peaked at $46K in Q4 2013. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- Tower Research Capital (TRC) reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,047 Acer Therapeutics Inc shares in Q4 2023, an estimated $853.
- Tower Research Capital (TRC) first reported a position in Acer Therapeutics Inc in Q4 2013 and held it in 24 quarters.
- Tower Research Capital (TRC)'s Acer Therapeutics Inc position peaked at $46K in Q4 2013.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.